Proportion of idiopathic pulmonary fibrosis risk explained by known Common genetic loci in European populations
File(s)2020.08.14.20172528v1.full.pdf (164.8 KB)
Working paper
Author(s)
Type
Working Paper
Abstract
Genome-wide association studies have identified 14 genetic loci associated with susceptibility to idiopathic pulmonary fibrosis (IPF), a devastating lung disease with poor prognosis. Of these, the variant with the strongest association, rs35705950, is located in the promoter region of the MUC5B gene and has a risk allele (T) frequency of 30-35% in IPF cases. Here we present estimates of the proportion of disease liability explained by each of the 14 IPF risk variants as well as estimates of the proportion of cases that can be attributed to each variant. We estimate that rs35705950 explains 5.9-9.4% of disease liability, which is much lower than previously reported estimates. Of every 100,000 individuals with the rs35705950_GG genotype we estimate 30 will have IPF, whereas for every 100,000 individuals with the rs35705950_GT genotype 152 will have IPF. Quantifying the impact of genetic risk factors on disease liability improves our understanding of the underlying genetic architecture of IPF and provides insight into the impact of genetic factors in risk prediction modelling.
Date Issued
2020-11-23
Date Acceptance
2020-11-23
Citation
American Journal of Respiratory and Critical Care Medicine, 2020, 203 (6), pp.775-778
ISSN
1073-449X
Publisher
American Thoracic Society
Start Page
775
End Page
778
Journal / Book Title
American Journal of Respiratory and Critical Care Medicine
Volume
203
Issue
6
Copyright Statement
© 2020 The Author(s). It is made available under a CC BY 4.0 International license.
License URL
Identifier
https://www.medrxiv.org/content/10.1101/2020.08.14.20172528v1
Publication Status
Published online
Article Number
rccm.202008-3211LE
Date Publish Online
2020-11-23